Search Results - "Mauff, Brigitte Le"

Basophil activation test: Feedback and lessons from routine practice in French clinical laboratories by Charpy, Juliette, Barbier, Ophélie, Le Mauff, Brigitte, Sarrat, Anne, Roland-Nicaise, Pascale, Goret, Julien

Get full text

Basal serum tryptase: A critical reconsideration of reference values by Francois, Fabien, Mauff, Brigitte Le, Waeckel, Louis, de Chaisemartin, Luc, Tabary, Thierry, Dumontet, Erwan, Lecron, Jean Claude, Delamare, Benoit, Boumediene, Ahmed, Chauvineau-Grenier, Angélique, Pescarmona, Remi, Garnier, Lorna, Lambert, Claude

Get full text

Rhupus: a systematic literature review by Antonini, Luca, Le Mauff, Brigitte, Marcelli, Christian, Aouba, Achille, de Boysson, Hubert

“…“Rhupus” or “rhupus syndrome” is a poorly described and underdiagnosed disease in which features of both rheumatoid arthritis (RA) and systemic lupus…”
Get full text

Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring by Khoy, Kathy, Mariotte, Delphine, Defer, Gilles, Petit, Gautier, Toutirais, Olivier, Le Mauff, Brigitte

“…Multiple sclerosis is a chronic demyelinating disease of the central nervous system (CNS) with an autoimmune component. Among the recent disease-modifying…”
Get full text

Stroke and the immune system: from pathophysiology to new therapeutic strategies by Macrez, Richard, PhD, Ali, Carine, PhD, Toutirais, Olivier, PhD, Le Mauff, Brigitte, MD, Defer, Gilles, MD, Dirnagl, Ulrich, MD, Vivien, Denis, Prof

“…Summary Stroke is the second most common cause of death worldwide and a major cause of acquired disability in adults. Despite tremendous progress in…”
Get full text

HLA-Class II Artificial Antigen Presenting Cells in CD4 + T Cell-Based Immunotherapy by Couture, Alexandre, Garnier, Anthony, Docagne, Fabian, Boyer, Olivier, Vivien, Denis, Le-Mauff, Brigitte, Latouche, Jean-Baptiste, Toutirais, Olivier

“…CD4 T cells differentiate into various T helper subsets characterized by distinct cytokine secreting profiles that confer them effector functions adapted to a…”
Get full text

Mediators of anaphylactic reactions: Tryptase and histamine stability in whole blood by Serrier, Julien, Khoy, Kathy, Petit, Gautier, Parienti, Jean‐Jacques, Laroche, Dominique, Mariotte, Delphine, Le Mauff, Brigitte

Get full text

Validation of an anti-α-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab by Serrier, Julien, Davy, Jean-Baptiste, Dupont, Benoît, Clarisse, Bénédicte, Parienti, Jean-Jacques, Petit, Gautier, Khoy, Kathy, Ollivier, Yann, Gervais, Radj, Mariotte, Delphine, Le Mauff, Brigitte

“…The link between immediate hypersensitivity reactions (HSR) following the first cetuximab infusion and the IgE sensitization against…”
Get full text

Tissue-plasminogen activator effects on the phenotype of splenic myeloid cells in acute inflammation by Seillier, Célia, Lesec, Léonie, Hélie, Pauline, Marie, Charlotte, Vivien, Denis, Docagne, Fabian, Le Mauff, Brigitte, Toutirais, Olivier

“…Tissue-plasminogen activator (tPA) is a serine protease well known for its fibrinolytic function. Recent studies indicate that tPA could also modulate…”
Get full text

Disease patterns and specific trajectories of anti-MDA5-related disease: a multicentre retrospective study of 70 adult patients by de Boysson, Hubert, Cuchet, Marie, Cassius, Charles, Cuchet, Pierre, Agard, Christian, Audemard-Verger, Alexandra, Marchand-Adam, Sylvain, Cohen-Sors, Raphaëlla, Gallay, Laure, Graveleau, Julie, Lesort, Cécile, Ly, Kim, Meyer, Alain, Monseau, Grégoire, Néel, Antoine, Bonnotte, Bernard, Pérard, Laurent, Schleinitz, Nicolas, Mariotte, Delphine, Le Mauff, Brigitte, Bourdenet, Gwladys, Masmoudi, Wafa, Deshayes, Samuel, Dumont, Anaël, Dompmartin, Anne, Kottler, Diane, Aouba, Achille

“…This study aimed to provide an updated analysis of the different prognostic trajectories of patients with anti-melanoma differentiation-associated gene 5…”
Get full text

Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses by Hélie, Pauline, Camacho-Toledano, Celia, Lesec, Léonie, Seillier, Célia, Miralles, Antonio J, Ortega, Maria Cristina, Guérit, Sylvaine, Lebas, Héloïse, Bardou, Isabelle, Vila-Del Sol, Virginia, Vivien, Denis, Le Mauff, Brigitte, Clemente, Diego, Docagne, Fabian, Toutirais, Olivier

“…Tissue plasminogen activator (tPA) is a serine protease involved in fibrinolysis. It is released by endothelial cells, but also expressed by neurons and glial…”
Get full text

CD49d expression as a promising biomarker to monitor natalizumab efficacy by Defer, Gilles, Mariotte, Delphine, Derache, Nathalie, Toutirais, Olivier, Legros, Hélène, Cauquelin, Brigitte, Le Mauff, Brigitte

“…Abstract Natalizumab (Tysabri™), a monoclonal antibody against the α4-integrin of VLA-4 (CD49d) antigen of leukocytes, is highly effective in multiple…”
Get full text

Utility of serum anti‐cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab by Dupont, Benoît, Mariotte, Delphine, Dugué, Audrey E., Clarisse, Bénédicte, Grellard, Jean‐Michel, Babin, Emmanuel, Chauffert, Bruno, Dakpé, Stéphanie, Moldovan, Cristian, Bouhier‐Leporrier, Karine, Reimund, Jean‐Marie, Di Fiore, Frederic, Zanetta, Sylvie, Mailliez, Audrey, Do, Pascal, Peytier, Annie, Galais, Marie‐Pierre, Florescu, Carmen, Schott, Roland, Le Mauff, Brigitte, Gervais, Radj

“…Aim Cetuximab is an anti‐epidermal growth factor receptor antibody used for the treatment of metastatic colorectal cancer and head and neck cancer…”
Get full text

B‐cell subpopulations in children: National reference values by Duchamp, Marie, Sterlin, Delphine, Diabate, Aminata, Uring‐Lambert, Béatrice, Guérin‐El Khourouj, Valérie, Le Mauff, Brigitte, Monnier, Delphine, Malcus, Christophe, Labalette, Myriam, Picard, Capucine

“…Peripheral B‐lymphocytes undergo a series of changes during the first few years of life. Encounters with foreign antigens lead to maturation and…”
Get full text

Anti-cetuximab IgE ELISA for identification of patients at a high risk of cetuximab-induced anaphylaxis by Mariotte, Delphine, Dupont, Benoît, Gervais, Radj, Galais, Marie-Pierre, Laroche, Dominique, Tranchant, Aurore, Comby, Elisabeth, Bouhier-Leporrier, Karine, Reimund, Jean-Marie, Le Mauff, Brigitte

“…Cetuximab, a chimeric mouse-human IgG1 monoclonal antibody against the epidermal growth factor receptor, has proven effective in the treatment of metastatic…”
Get full text

Transgenic expression of CTLA4-Ig by fetal pig neurons for xenotransplantation by MARTIN, Caroline, PLAT, Martine, ANEGON, Ignacio, MELCHIOR, Benoit, PESCHANSKI, Marc, LE MAUFF, Brigitte, BOEFFARD, Francoise, SERGENT-TANGUY, Solène, NEVEU, Isabelle, NAVEILHAN, Philippe, SOULILLOU, Jean-Paul, TERQUI, Michel, NERRIERE-DAGUIN, Véronique, BRACHET, Philippe, VANHOVE, Bernard, COULON, Flora, UZBEKOVA, Svetlana, VENTURI, Eric, CONDE, Francoise, HERMEL, Jean-Michel, HANTRAYE, Philippe, TESSON, Laurent

“…The transplantation of fetal porcine neurons is a potential therapeutic strategy for the treatment of human neurodegenerative disorders. A major obstacle to…”
Get full text

Adenovirus-mediated CTLA4Ig or CD40Ig gene transfer delays pancreatic islet rejection in a rat-to-mouse xenotransplantation model after systemic but not local expression by Potiron, Nicolas, Chagneau, Carine, Boeffard, Françoise, Soulillou, Jean-Paul, Anegon, Ignacio, Le Mauff, Brigitte

“…Transient costimulation signal blockade of either CD28/CD80-86 interactions and/or CD40/CD154 interactions can prevent islet rejection in some models of both…”
Get full text

Roles of the tissue-type plasminogen activator in immune response by Seillier, Célia, Hélie, Pauline, Petit, Gautier, Vivien, Denis, Clemente, Diego, Le Mauff, Brigitte, Docagne, Fabian, Toutirais, Olivier

“…•Functional crosstalk exist between hemostasis and immunological processes.•tPA is a fibrinolytic enzyme that also contributes to the immune system.•The…”
Get full text

Interleukin 10 (IL10) and IL15 Significantly Decreased in Chronic Myeloid Leukemia Patients Presenting with Tyrosine Kinase Inhibitor (TKI) Withdrawal Syndrome (TWS). Results from the Prospective, Explorative and Multicenter « Kiwis » Study Designed for TWS. Clinicaltrial.Gov ID: NCT03996096; Study Number: 18-206 by Johnson-Ansah, Hyacinthe A., Briant, Anaïs, Charbonnier, Amandine, Cambier, Nathalie, Damaj, Gandhi Laurent, Lenain, Pascal, Henry, Alexandra, Parienti, Jean-Jacques, Guenet, David, GAC Besnard, Anne-Claire, Delapierre, Baptiste, Nicolini, Franck E., Le Mauff, Brigitte, Berger, Marc G.

“…Aims Treatment-free remission (TFR) has been included in practice guidelines as a new management goal for chronic myeloid leukemia (CML) patients, implying…”
Get full text

Validation of an anti-[alpha]-Gal IgE fluoroenzyme-immunoassay for the screening of patients at risk of severe anaphylaxis to cetuximab by Serrier, Julien, Davy, Jean-Baptiste, Dupont, Benoît, Clarisse, Bénédicte, Parienti, Jean-Jacques, Petit, Gautier, Khoy, Kathy, Ollivier, Yann, Gervais, Radj, Mariotte, Delphine, Le Mauff, Brigitte

“…Background The link between immediate hypersensitivity reactions (HSR) following the first cetuximab infusion and the IgE sensitization against…”
Get full text